Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Golden Throat Holdings Group Co's EBIT per Share for the
six
months ended in Dec. 2025 was HK$0.35.
Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 was HK$0.45.
During the past 12 months, the average EBIT per Share Growth Rate of Golden Throat Holdings Group Co was -23.70% per year.
During the past 3 years, the average EBIT per Share Growth Rate was -5.20% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 14.50% per year.
During the past 10 years, the average EBIT per Share Growth Rate was 9.50% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Golden Throat Holdings Group Co's EBIT per Share or its related term are showing as below:
HKSE:06896'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -30.1 Med: 12.1 Max: 27.9
Current: -5.2
During the past 12 years, the highest 3-Year average EBIT per Share Growth Rate of Golden Throat Holdings Group Co was 27.90% per year. The lowest was -30.10% per year. And the median was 12.10% per year.
HKSE:06896's 3-Year EBIT Growth Rate is ranked worse than 70.58% of 809
companies
in the Drug Manufacturers industry
Industry Median: 7.8
vs HKSE:06896: -5.20
Golden Throat Holdings Group Co (HKSE:06896) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Golden Throat Holdings Group Co EBIT per Share Related Terms
Golden Throat Holdings Group Co EBIT per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Golden Throat Holdings Group Co EBIT per Share Chart
EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0.45
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Golden Throat Holdings Group Co (HKSE:06896) has a EBIT per Share of HK$0.45 as of Dec. 2025. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Golden Throat Holdings Group Co and its competitors. According to the industry distribution chart, Golden Throat Holdings Group Co ranks #571 out of 809 companies in the Drug Manufacturers industry, placing it in the top 70.6%.
Is Golden Throat Holdings Group Co's EBIT per Share too high?
Golden Throat Holdings Group Co's current EBIT per Share is HK$0.45. Based on the distribution chart, Golden Throat Holdings Group Co ranks #571 out of 809 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Golden Throat Holdings Group Co has a GF Score™ of 83/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Golden Throat Holdings Group Co's EBIT per Share compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Golden Throat Holdings Group Co ranks #571 out of 809 companies for EBIT per Share. This places Golden Throat Holdings Group Co in the lower half of its industry. The industry median EBIT per Share is 7.80. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Drug Manufacturers company?
The median EBIT per Share among Drug Manufacturers companies is 7.80, based on 809 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Golden Throat Holdings Group Co and its competitors. For the Drug Manufacturers industry, the median EBIT per Share is 7.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Golden Throat Holdings Group Co's current EBIT per Share is HK$0.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Golden Throat Holdings Group Co stock overvalued right now?
Based on GuruFocus' analysis, Golden Throat Holdings Group Co (HKSE:06896) is currently considered Modestly Undervalued. The stock's GF Value™ is HK$2.98, compared to a current price of HK$2.28 — trading 23.7% below its estimated fair value. The current EBIT per Share is HK$0.45. Golden Throat Holdings Group Co's overall GF Score™ is 83/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Golden Throat Holdings Group Co (HKSE:06896), the current EBIT per Share is HK$0.45 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Golden Throat Holdings Group Co (HKSE:06896) Overvalued in 2026?
Based on GuruFocus' analysis, Golden Throat Holdings Group Co stock appears to be undervalued.
The current stock price of HK$2.28 is trading 23.7% below its estimated GF Value™ of HK$2.98.
GuruFocus considers Golden Throat Holdings Group Co to be Modestly Undervalued.
Key valuation signals for HKSE:06896:
EBIT per Share: HK$0.45
GF Value™: HK$2.98 vs. price of HK$2.28 (23.7% below fair value)
No single metric tells the full story. See the HKSE:06896 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Golden Throat Holdings Group Co Ltd is an investment holding company. Through its subsidiaries, the company is engaged in the manufacture and sale of pharmaceuticals, healthcare food and other products. The compqny manufactures and sells lozenges and other pharmaceutical and food products. The key products of the group that derives revenue for the group are Golden Throat Lozenges (OTC), Golden Throat Lozenge Series products and other products. The group derives majority of its revenue from Mainland China.
83GF Score
Get the complete analysis for HKSE:06896
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:06896 has been successfully added to your 
